Birchcreek Wealth Management, LLC Pfizer Inc Transaction History

Birchcreek Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $20,530 - $23,575	793 Added 11.2%	7,872 $218,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $2,247 - $2,918	-86 Reduced 1.2%	7,079 $203,000
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $45,824 - $53,564	1,428 Added 24.89%	7,165 $237,000
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $5,706 - $6,602	158 Added 2.83%	5,737 $210,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $11,508 - $14,049	-263 Reduced 4.5%	5,579 $244,000
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $38,201 - $45,294	821 Added 16.35%	5,842 $306,000
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $15,051 - $18,651	-329 Reduced 6.15%	5,021 $260,000
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $4,958 - $7,350	-120 Reduced 2.19%	5,350 $316,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $196,427 - $222,519	5,470 New	5,470 $214,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $167,751 - $189,189	-5,009 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $167,651 - $213,183	5,009 New	5,009 $184,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Birchcreek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Birchcreek Wealth Management, LLC with notifications on news.